Survival of cervical cancer patients and its prognostic factors at Cipto Mangunkusumo Hospital, Jakarta

Laila Nuranna, Rahma Prastasari, Bambang Sutrisna



DOI: https://doi.org/10.13181/mji.v23i3.739

Abstract


Background: Cervical cancer is the second most common cancer among Indonesian women. Information concerning survival probability is very important for the patient and institution. Our last data about cervical cancer survival was studied for more than 10 years ago. This study aimed to know the latest cervical cancer survival and its prognostic factors.
Methods: This is a retrospective cohort study which enrolled cervical cancer patients treated at Cipto Mangunkusumo Hospital in 2005-2006. Subjects were followed-up for minimum of 5 years. Kaplan-Meier and Cox regression analysis was used to determine the survival probability and to assess prognostic factors.

Results: A total of 447 patients who met the study criteria were selected. Stage III was the largest proportion on the study (41.6%). Most of the histopathology type was squamous cell carcinoma (71.6%). This study revealed that median survival was 63 months with the overall 5-years survival probability to be 52%. Tumor size did not influence overall survival rate. Stage III and IV had lower survival probability (HR 3.27 and 6.44). Poor differentiation and uncompleted therapy also had lower survival probability (HR 2.26 and 2.22). Histopathology of others (neuroendocrine) had lower survival probability (HR 2.85). However, it was not statistically significant on multivariate analysis.

Conclusion: Median survival time for cervical cancer patients at Cipto Mangunkusumo Hospital was 63 months. There were improvement in the survival rate comparing from the study in 1997. In this study, the independent prognostic factors for survival were tumor staging, tumor differentiation, and completion of therapy.


Keywords


cervical cancer; prognostic factors; survival rate

Full Text:

PDF

References


  1. American Cancer Society. Global cancer facts and figures. 2nd ed. Atlanta: American Cancer Society; 2011.
  2. Persatuan Dokter Spesialis Patologi Indonesia. Kanker di Indonesia tahun 2008: data histopatologik. Jakarta: Yayasan Kanker Indonesia; 2012. [Indonesian].
  3. Sirait AM, Ariawan I, Aziz F. Ketahanan hidup penderita kanker serviks di Rumah Sakit Dr Cipto Mangunkusumo Jakarta. Maj Obstet Ginekol Indones. 1997;21(3):183-90. [Indonesian].
  4. N, Triaspolitica. "Mengenal Penyakit Kanker, Jenis, Gejala, Penyebab Berikut Pengobatan Kanker." Mau Nanya Dong Dok. N.p, 20 June 2017. Web. 28 June 2017. <https://nanyadongdok.blogspot.com/2017/06/mengenal-penyakit-kangker-jenis-gejala.html>.
  5. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S43-103. http://dx.doi.org/10.1016/S0020-7292(06)60030-1
  6. Atahan IL, Onal C, Ozyar E, Yiliz F, Selek U, Kose F. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. Int J Gynaecol Obstet. 2007;17(4):833-42.
  7. Seamon LG, Tarrant RL, Fleming ST, Vanderpool RC, Pachtman S, Podzielinski I, et al. Cervical cancer survival for patients referred to a tertiary care center in Kentucky. Gynecol Oncol. 2011;123(3):565-70. http://dx.doi.org/10.1016/j.ygyno.2011.09.008
  8. Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG. Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer. 2009;115(1):166-78. http://dx.doi.org/10.1002/cncr.24007
  9. Swangvaree SS, Adulbhan A, Talacheep S, Thepsuwan D, Tabtimsri K, Boonpen P, et al. Cervical cancer survival at the National Cancer Institute, Thailand. Thai Cancer Journal. 2010;30(3):87-93.
  10. Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR. Cervical cancer survival by socioeconomic status, race/ethnicity, and place of residence in Texas, 1995-2001. J Womens Health (Larchmt). 2006;15(8):941-51. http://dx.doi.org/10.1089/jwh.2006.15.941
  11. Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol. 2012;125(2):287-91. http://dx.doi.org/10.1016/j.ygyno.2012.01.012
  12. Brewster WR, DiSaia PJ, Monk BJ, Ziogas A, Yamada SD, Anton-Culver H. Young age as a prognostic factor in cervical cancer: results of a population-based study. Am J Obstet Gynecol. 1999;180(6 Pt 1):1464-7. http://dx.doi.org/10.1016/S0002-9378(99)70038-4
  13. Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol. 2012;125(2):292-6. http://dx.doi.org/10.1016/j.ygyno.2012.01.034





Copyright (c) 2014 Laila Nuranna, Rahma Prastasari, Bambang Sutrisna

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles and issues in Medical Journal of Indonesia have unique DOI number registered in Crossref.
 
Romeo